Lv1
40 积分 2025-06-15 加入
Clearance of solvents and small molecule impurities in antibody drug conjugates via ultrafiltration and diafiltration operation
4小时前
已完结
CMC Regulatory Considerations for Antibody-Drug Conjugates
5小时前
已完结
Antibody–drug conjugates come of age in oncology
8小时前
已完结
“Negative” Impact: The Role of Payload Charge in the Physicochemical Stability of Auristatin Antibody–Drug Conjugates
21天前
已完结
Homogeneous Dual-Payload Antibody-Drug Conjugates Produced by Combined Distinct Conjugation Strategies
3个月前
已完结
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
3个月前
已完结
Dual-payload ADCs move into first oncology clinical trials
3个月前
已完结
First-in-class PD-1/IL-2 bispecific antibody IBI363 in patients (Pts) with advanced immunotherapy-treated non-small cell lung cancer (NSCLC)
4个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
4个月前
已完结
One-step synthesis of site-specific antibody–drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates
5个月前
已完结
皖公网安备34019202002308
